Calithera is discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.


Tumor Metabolism

The field of tumor metabolism seeks to exploit the unique ways in which cancer cells take up and utilize nutrients in order to grow and survive. Our lead product candidate in tumor metabolism takes advantage of the pronounced dependency many cancers have on the nutrient glutamine for growth and survival.

More about CB-839 →


Tumor Immunology

Tumor immunology seeks to activate the body’s own immune system to attack and kill cancer cells. Our preclinical program in tumor immunology is focused on developing selective inhibitors of the enzyme arginase.

More about Arginase Inhibitors →

Back to Top